ATOPIX THERAPEUTICS
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The company is developing a novel class of oral anti-allergic medicines, called CRTH2 antagonists, to treat atopic dermatitis, asthma and allergic rhinitis. Its lead candidate is currently being studied in a Phase 2 clinical trial for moderate to severe atopic dermatitis in several leading European dermatology centres.
ATOPIX THERAPEUTICS
Industry:
Biotechnology Life Science Medical
Founded:
2012-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.atopixtherapeutics.co.uk
Total Employee:
1+
Status:
Closed
Contact:
(440) 123-5841
Email Addresses:
[email protected]
Total Funding:
10.46 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF LetsEncrypt SSL By Default Nginx GStatic Google Static Content OVH Cart Functionality
Current Advisors List
Current Employees Featured
Investors List
SV Health Investors
SV Health Investors investment in Venture Round - Atopix Therapeutics
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Atopix Therapeutics
Wellington Partners
Wellington Partners investment in Series A - Atopix Therapeutics
SR One
SR One investment in Series A - Atopix Therapeutics
Bessemer Venture Partners
Bessemer Venture Partners investment in Series A - Atopix Therapeutics
Red Abbey Venture Partners
Red Abbey Venture Partners investment in Series A - Atopix Therapeutics
MPM Capital
MPM Capital investment in Series A - Atopix Therapeutics
Biomedical Catalyst Fund
Biomedical Catalyst Fund investment in Grant - Atopix Therapeutics
Official Site Inspections
http://www.atopixtherapeutics.co.uk
- Host name: 104.247.82.54
- IP address: 104.247.82.54
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Atopix Therapeutics"
Home | Atopix
A solution for every need . Atopix is focused on the development of Th2 mediated eosinophilic asthma research. Allergic disease includes common conditions such as asthma and …See details»
Atopix Therapeutics - Crunchbase Company Profile
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The …See details»
About Us | Atopix - atopixtherapeutics.com
Tony Fred, CEO. Founder and chief visionary, Tony is the driving force behind the company. He loves to keep his hands full by participating in the development of the software, marketing, and …See details»
Atopix Company Profile 2024: Valuation, Investors, Acquisition
Atopix General Information Description. Developer of novel treatments designed for Th2-mediated eosinophilic asthma. The company is developing a novel class of oral anti-allergic medicines, …See details»
Chiesi Enhances Asthma Portfolio with Acquisition of …
Parma, Italy — November 21, 2016— Chiesi Farmaceutici Spa (“Chiesi”), announced today that it has signed a definitive agreement for the acquisition of Atopix Therapeutics Limited, a UK clinical stage biotechnology company …See details»
Atopix Therapeutics - VentureRadar
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The company is developing a novel …See details»
Atopix Therapeutics Ltd - Company Profile and News
Atopix Therapeutics Ltd. operates as a clinical-stage, biopharmaceutical company. The Company develops anti-inflammatory medicines to treat asthma, chronic allergic conditions, and other …See details»
ATOPIX THERAPEUTICS LIMITED - Companies House
ATOPIX THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Organization | Atopix Therapeutics, Ltd. - Purdue University
Atopix Therapeutics, Ltd. Report issue. For profit Phase 1 Phase 2. Founded: Oxford United Kingdom (2012 ... Organization Overview. First Clinical Trial. 2013 NCT02002208. First …See details»
ATOPIX THERAPEUTICS LIMITED overview - Find and update …
Insolvency for ATOPIX THERAPEUTICS LIMITED (08247158) More for ATOPIX THERAPEUTICS LIMITED (08247158) Registered office address C/O Interpath Ltd, 10 Fleet …See details»
Atopix Therapeutics - 2025 Company Profile - Tracxn
3 days ago Atopix Therapeutics is an acquired company based in Abingdon (United Kingdom), founded in 2012. It operates as a Medicines to treat atopic dermatitis and severe asthma. …See details»
Atopix Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Atopix Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, and 1 literature, Drug:Timapiprant, ATX-2417, ATX-2286.See details»
Atopix Company Profile - Office Locations, Competitors, Revenue …
Atopix Therapeutics Limited is a clinical stage biotechnology company developing novel treatments for Th2-mediated eosinophilic asthma. The company is developing a novel class of …See details»
Atopix Therapeutics - Overview, News & Competitors - ZoomInfo
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The company is developing a novel …See details»
Atopix Therapeutics - Company Profile & Staff Directory
Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The company is developing a novel …See details»
Atopix Therapeutics - Contacts, Employees, Board Members
Organization. Atopix Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. ... Atopix Therapeutics has 3 current employee …See details»
Atopix Therapeutics | Biotechnology | The Pharmaletter | The …
Atopix Therapeutics is a clinical stage biotechnology company developing novel treatments for Th2-mediated eosinophilic asthma. Its lead candidate, OC459, is being studied in a Phase II …See details»
ATOPIX THERAPEUTICS LIMITED filing history - Companies House
ATOPIX THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Atopix Appoints Dr Andrew Zambanini As Chief Medical Officer
Sep 4, 2015 Atopix Therapeutics Limited is a clinical-stage biotechnology company developing novel treatments for Th2-mediated diseases including atopic dermatitis and severe asthma. …See details»
Atopix obtains £1.7m grant to advance ... - Clinical Trials Arena
May 29, 2013 Biopharmaceutical company Atopix Therapeutics has obtained a £1.7m grant from the UK Biomedical Catalyst fund to advance the development of OC459 as a treatment for …See details»